Advertisement

Ads Placeholder
Loading...

Atossa Therapeutics, Inc.

ATOS•NASDAQ
Healthcare
Biotechnology
$4.82
$-0.06(-1.23%)
U.S. Market is Open • 10:14

Atossa Therapeutics, Inc. (ATOS) Stock Overview

Explore Atossa Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap41.5M
P/E Ratio-1.22
EPS (TTM)$-4.04
ROE-0.66%
Fundamental Analysis

AI Price Forecasts

1 Month$4.26
3 Months$3.45
1 Year Target$1.10

ATOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Atossa Therapeutics, Inc. (ATOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.22 and a market capitalization of 41.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.23%
5-Day Change
-10.91%
1-Month Change
6.40%
3-Month Change
-50.82%
6-Month Change
-71.05%
Year-to-Date (YTD) Change
-49.05%
1-Year Change
-45.66%
3-Year Change
-54.74%
5-Year Change
-84.40%
All-Time (Max) Change
-99.96%

Contact Information

https://www.atossatherapeutics.com
206 588 0256
107 Spring Street, Seattle, WA, 98104

Company Facts

150 Employees
IPO DateNov 8, 2012
CountryUS
Actively Trading

Frequently Asked Questions